Pharma Mar SA is a biopharmaceutical holding company, which engages in discovery and development of innovative marine-derived anticancer drugs. It operates through the following segments: Oncology, Diagnostics, RNAi, and Consumer Chemicals. The Oncology segment encompasses the Group undertakings whose object is to research, develop and market anti-tumour drugs. The Diagnostics segment develops and markets diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The Consumer Chemicals segment comprises Group undertakings that produce and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. The company was founded on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.